Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: A systematic review and meta-analysis
Cancer Epidemiology · 2023
DOI: 10.1016/j.canep.2023.102409 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Epidemiology, 2023. Verfasst von Stanley Nkemjika und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Interfaith Medical Center, Brooklyn, NY, USA. Electronic address: snkemjika@interfaithmedical.org. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Renal cell carcinoma (RCC), a type of kidney cancer has biological sex-based differences that play a role in cancer incidence. Specifically, the incidence of urinary system cancers in men is two times greater than in women, while the incidence of genital cancers is three times greater. There is conflicting epidemiologic and limited evidence in the literature to suggest apparent biological sex discrepancy. The primary objective of this review and meta-analysis is to synthesize evidence to understand biological sex disparity in the survival outcomes of RCC following any treatment intervention. METHODS: A three-step search strategy was utilized in this review. We searched MEDLINE, EMBASE and PsycINFO databases for manuscript on biological sex differences in treatment outcomes. Study screening, critical appraisal, and data extraction were executed independently by pairs of reviewers among co-authors. Studies that had any form of treatment modality in the management of RCC were included. Study designs included observational studies in the form of prospective and retrospective studies that utilized cox proportional hazard assumption to conduct survival analysis. The data synthesis was carried out using the R metafor software package (Software version of 1.2.8) and Microsoft Office Excel 2019 package (Microsoft Corporation, USA). The random effects model was estimated using restricted maximum likelihood estimation (REML). Data synthesis included narrative review and meta-analysis. RESULTS: We had 23 eligible studies for this review. On review of the full text, 35 studies were excluded due to irrelevances to measure estimates utilized. Finally, 12 studies were selected for the meta-analysis with a total of n = 21,2453 individuals. Females had a better survival outcome following a treatment intervention for RCC than their male counterpart [Mean effect size = -0.1737 (95 % CI: -0.2524, -0.0949)]. CONCLUSION: Females were more likely to be cancer free than their male counterpart following treatment for RCC. This finding will inform appropriate decision making for stakeholders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Interfaith Medical Center, Brooklyn, NY, USA. Electronic address: snkemjika@interfaithmedical.org.
- River Valley Health and Dental Center, Williamsport, PA, USA.
- Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA.
- Department of Family Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, USA; The Northeast Institute for Evidence Synthesis and Translation (NEST), JBI Center of Excellence, Rutgers School of N…
Zitieren
APA
Nkemjika, S., Tokede, O., Okosun, I. S., Jadotte, Y., & Pigott, T. (2023). Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: A systematic review and meta-analysis. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2023.102409
Vancouver
Nkemjika S, Tokede O, Okosun IS, Jadotte Y, Pigott T. Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: A systematic review and meta-analysis. Cancer Epidemiology. 2023. doi:10.1016/j.canep.2023.102409
BibTeX
@article{Nkemjika2023,
author = {Nkemjika, Stanley and Tokede, Oluwatosin and Okosun, Ike S and Jadotte, Yuri and Pigott, Therese},
title = {Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: A systematic review and meta-analysis},
journal = {Cancer Epidemiology},
year = {2023},
doi = {10.1016/j.canep.2023.102409}
}
EUVIMED